Literature DB >> 8563097

Smoking promotes insidious and chronic farmer's lung disease, and deteriorates the clinical outcome.

Y Ohtsuka1, M Munakata, K Tanimura, H Ukita, H Kusaka, Y Masaki, I Doi, M Ohe, M Amishima, Y Homma.   

Abstract

Although the prevalence of serum precipitating antibodies for farmer's lung disease (FLD) is lower in smokers than in nonsmokers and FLD predominates in nonsmokers, the affects of smoking on the clinical course of the disease is not known. We compared the clinical findings and the prognosis between 12 smokers (SM-FLD) and 31 non-smokers with FLD (NS-FLD). There was no difference in age, sex, working years on farm, clinical symptoms, laboratory findings, radiographic findings, between the two groups. However, for the type of onset on the first visit for FLD, "acute single episode" type was less common, and "recurrent" and "insidious onset" types were more common in SM-FLD than in NS-FLD (8.3 vs 58.1, 91.7 vs 41.9%, respectively, p < 0.05). Although working status and mask wearing status were not significantly different between the two groups after the diagnosis of FLD, patients with symptoms and/or radiographic abnormalities of FLD of more than 6 months were found more frequently in SM-FLD than in NS-FLD (66.7 vs 19.4%, p < 0.005). And also SM-FLD had more recurrences of FLD than NS-FLD after the initial diagnosis of FLD (1.58 +/- 1.56 vs 0.47 +/- 1.07, p < 0.05). SM-FLD tended to have lower % VC than NS-FLD (73.6 +/- 7.4 vs 88.5 +/- 3.9%, respectively, p = 0.06). Regarding the prognosis, the 10-year survival rates were 70.7% in SM-FLD, and 91.5% in NS-FLD (p < 0.05). These results suggest that smoking may make FLD insidious and chronic, and deteriorates the clinical outcome.

Entities:  

Mesh:

Year:  1995        PMID: 8563097     DOI: 10.2169/internalmedicine.34.966

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  12 in total

1.  Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis.

Authors:  Evans R Fernández Pérez; Jeffrey J Swigris; Anna V Forssén; Olga Tourin; Joshua J Solomon; Tristan J Huie; Amy L Olson; Kevin K Brown
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

Review 2.  Hypersensitivity pneumonitis.

Authors:  Ulrich Costabel; Yasunari Miyazaki; Annie Pardo; Dirk Koschel; Francesco Bonella; Paolo Spagnolo; Josune Guzman; Christopher J Ryerson; Moises Selman
Journal:  Nat Rev Dis Primers       Date:  2020-08-06       Impact factor: 52.329

3.  CT findings associated with survival in chronic hypersensitivity pneumonitis.

Authors:  Jonathan H Chung; Steven M Montner; Ayodeji Adegunsoye; Justin M Oldham; Aliya N Husain; Rekha Vij; Imre Noth; Mary E Strek
Journal:  Eur Radiol       Date:  2017-07-07       Impact factor: 5.315

Review 4.  Cigarette smoking and diffuse lung disease.

Authors:  Rajesh R Patel; Jay H Ryu; Robert Vassallo
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 5.  Agricultural lung diseases.

Authors:  S R Kirkhorn; V F Garry
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

6.  Beryllium increases the CD14(dim)CD16+ subset in the lung of chronic beryllium disease.

Authors:  Li Li; Nabeel Hamzeh; May Gillespie; Jill Elliott; Jieru Wang; Eva Brigitte Gottschall; Peggy M Mroz; Lisa A Maier
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

Review 7.  Chronic hypersensitivity pneumonitis.

Authors:  Carlos Ac Pereira; Andréa Gimenez; Lilian Kuranishi; Karin Storrer
Journal:  J Asthma Allergy       Date:  2016-09-21

8.  Chronic hypersensitivity pneumonitis: identification of key prognostic determinants using automated CT analysis.

Authors:  Joseph Jacob; Brian J Bartholmai; Ryoko Egashira; Anne Laure Brun; Srinivasan Rajagopalan; Ronald Karwoski; Maria Kokosi; David M Hansell; Athol U Wells
Journal:  BMC Pulm Med       Date:  2017-05-04       Impact factor: 3.317

9.  A Gene-Environment Interaction Between Smoking and Gene polymorphisms Provides a High Risk of Two Subgroups of Sarcoidosis.

Authors:  Natalia V Rivera; Karina Patasova; Susanna Kullberg; Lina Marcela Diaz-Gallo; Tomoko Iseda; Camilla Bengtsson; Lars Alfredsson; Anders Eklund; Ingrid Kockum; Johan Grunewald; Leonid Padyukov
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379

10.  Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Christopher J Ryerson; Jeffrey L Myers; Michael Kreuter; Martina Vasakova; Elena Bargagli; Jonathan H Chung; Bridget F Collins; Elisabeth Bendstrup; Hassan A Chami; Abigail T Chua; Tamera J Corte; Jean-Charles Dalphin; Sonye K Danoff; Javier Diaz-Mendoza; Abhijit Duggal; Ryoko Egashira; Thomas Ewing; Mridu Gulati; Yoshikazu Inoue; Alex R Jenkins; Kerri A Johannson; Takeshi Johkoh; Maximiliano Tamae-Kakazu; Masanori Kitaichi; Shandra L Knight; Dirk Koschel; David J Lederer; Yolanda Mageto; Lisa A Maier; Carlos Matiz; Ferran Morell; Andrew G Nicholson; Setu Patolia; Carlos A Pereira; Elisabetta A Renzoni; Margaret L Salisbury; Moises Selman; Simon L F Walsh; Wim A Wuyts; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 30.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.